Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Y-MABS THERAPEUTICS, INC.

(YMAB)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Event chart Y-MABS THERAPEUTICS, INC.
Upcoming events on Y-MABS THERAPEUTICS, INC.
03/25/22 FY 2021 Earnings Release (Projected)
05/13/22 Q1 2022 Earnings Release (Projected)
08/17/22 Interim 2022 Earnings Release (Projected)
11/16/22 Q3 2022 Earnings Release (Projected)
Past events on Y-MABS THERAPEUTICS, INC.
01/11/22 | 09:00am JP Morgan Healthcare Conference
01/05/22 LifeSci Partners Corporate Access Event
12/15/21 | 12:00pm R&D Day
11/05/21 | 08:00am Q3 2021 Earnings Call
11/04/21 | 03:05pm Q3 2021 Earnings Release
10/21/21 International Society of Pediatric Oncology Virtual Congress - Omburtamab
10/21/21 International Society of Pediatric Oncology Virtual Congress - DANYELZA
09/23/21 | 12:00pm Investor Meeting - Key Opinion Leader
08/10/21 Wedbush Pacgrow Healthcare Conference
08/06/21 | 09:00am Interim 2021 Earnings Call
Past dividends on Y-MABS THERAPEUTICS, INC.

- No events available -

Annual results
Fiscal Period : December20172018201920202021
Sales
M $
Released
Forecast
Spread


 


 


 
20,8
10,9
90%
 
66,7
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread


 
-43,2
-25,0
-73%
-82,8
-86,2
3,9%
-120
-138
13%
 
-93,8
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread


 
-43,2
-37,6
-15%
-83,0
-84,9
2,2%
-120
-127
5,9%
 
-80,3
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread


 
-43,3
-39,7
-9,0%
-81,0
-83,1
2,5%
-119
-120
0,81%
 
-47,0
 
Net income
M $
Released
Forecast
Spread
-19,2

 
-43,3
-41,0
-5,5%
-81,0
-83,2
2,6%
-119
-126
5,0%
 
-49,0
 
EPS
$
Released
Forecast
Spread
-0,99

 
-1,50
-1,37
-9,5%
-2,30
-2,35
2,0%
-2,97
-3,16
6,1%
 
-1,10
 
Announcement Date06/08/201803/22/201903/12/202002/25/2021-
Quarterly results
Fiscal Period : December2020 Q32020 Q42021 Q12021 Q22021 Q32021 Q4
Sales
M $
Released
Forecast
Spread


 
20,8
10,9
91%
5,38
35,6
-85%
11,0
7,33
49%
8,97
10,9
-18%
 
10,9
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-32,5
-39,8
18%
-20,0
-41,0
51%
-28,1
20,0
-241%
-22,5
-30,0
25%
-28,6
-27,0
-5,8%
 
-32,0
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-32,6
-33,2
1,6%
-20,1
-26,9
25%
-28,3
-3,39
-734%
-22,7
-29,7
23%
-28,7
-26,5
-8,5%
 
-30,6
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-32,8
-31,8
-3,2%
-19,9
-20,9
4,5%
33,4
25,5
31%
-22,9
-28,4
19%
-28,9
-24,8
-16%
 
-28,7
 
Net income
M $
Released
Forecast
Spread
-32,8
-32,8
-0,11%
-19,9
-26,2
24%
33,4
28,8
16%
-22,9
-28,8
20%
-28,9
-26,2
-10%
 
-30,3
 
EPS
$
Released
Forecast
Spread
-0,82
-0,82
-0,00%
-0,48
-0,60
20%
0,75
0,61
23%
-0,53
-0,67
21%
-0,66
-0,56
-17%
 
-0,69
 
Announcement Date11/05/202002/25/202105/06/202108/05/202111/04/2021-
Previous year Next Year
Upcoming sector events for Y-MABS THERAPEUTICS, INC.
More events
Past sector events for Y-MABS THERAPEUTICS, INC.
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise